More Info: Chart | News | Historical Prices
Research Abstract - Ambit Biosciences Corporation (ambi)
Resources
· Report Screener
· Stock Screener
· Research by Industry
· Earnings Dates
· Up/Downgrades
Summary
Symbol(s): AMBI
Date:  12-Apr-14
Author: Hunter Orr
Contributor: Alpha Street Research
Title: AMBI - Ambit Biosciences Corp - Rated a Hold - Company Analysis and ASR Ranking Report
Document Size:  9 pages
Price:  $24
Document Type:  Adobe Acrobat Reader®
Download free Adobe Acrobat Reader®
Research Reports Premium Services
· Get the full report for $24.
· You will have access to this report for 24 hours.
Preview: Next 4
Synopsis
www.AlphaStreetResearch.com - Full Coverage of 3,000 U.S. equities. Reports include Financials, Ratios, Competitor Comparison, and our proprietary ASR Ranking indicating Buy/Sell/Hold. Ambit Biosciences Corporation operates as a biopharmaceutical company. The Company discovers and develops small molecule and orally administered enzyme inhibitors for the treatment of acute myeloid leukemia and inflammatory diseases. Ambit Biosciences operates in the United States.



Copyright © 2009 Yahoo Inc. All rights reserved.Privacy Policy - Terms of Service
To learn more about Yahoo's use of personal information, please read the Privacy Policy

Company information © 2005 Reuters. All Rights Reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
See our Important Disclaimers and Legal Information.